Evidence map›Paper›PMID 25035431›Full record

ArticleThe Journal of biological chemistry2014

FUN26 (function unknown now 26) protein from saccharomyces cerevisiae is a broad selectivity, high affinity, nucleoside and nucleobase transporter.

Rebba C Boswell-Casteel, Jennifer M Johnson, Kelli D Duggan, Zygy Roe-Žurž, Hannah Schmitz, Carter Burleson, Franklin A Hays

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Equilibrative nucleoside transporters-A review.Nucleosides, nucleotides & nucleic acids · 2017
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rebba C Boswell-CasteelFrom the Department of Biochemistry and Molecular Biology and.
Jennifer M JohnsonFrom the Department of Biochemistry and Molecular Biology and.
Kelli D DugganFrom the Department of Biochemistry and Molecular Biology and.
Zygy Roe-Žuržthe Department of Biochemistry and Biophysics, University of California, San Francisco, California 94143.
Hannah SchmitzFrom the Department of Biochemistry and Molecular Biology and.
Carter BurlesonFrom the Department of Biochemistry and Molecular Biology and.
Franklin A HaysFrom the Department of Biochemistry and Molecular Biology and the Stephenson Oklahoma Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 and Franklin-Hays@ouhsc.edu.
University of Oklahoma Health Sciences Center · USUniversity of California, San Francisco · US

Funding

TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)P20GM103639 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI HANNAFON, BETHANY · 2012 to 2022
$21.3M
STRUCTURAL BIOLOGY TRAINING PROGRAMT32GM008284 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 1988 to 2022
$10.1M
Integrative Program in Complex Biological System (ipCBS)T32EB009383 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARSHALL, WALLACE, WEINER, ORION D · 2009 to 2022
$3.2M
NIBIB NIH HHS T32 EB009383NIGMS NIH HHS P20 GM103639NIGMS NIH HHS P20GM103639NIGMS NIH HHS T32 GM008284
6 · The paper itself

Abstract

Equilibrative nucleoside transporters (ENTs) are polytopic integral membrane proteins that transport nucleosides and, to a lesser extent, nucleobases across cell membranes. ENTs modulate efficacy for a range of human therapeutics and function in a diffusion-controlled bidirectional manner. A detailed understanding of ENT function at the molecular level has remained elusive. FUN26 (function unknown now 26) is a putative ENT homolog from S. cerevisiae that is expressed in vacuole membranes. In the present system, proteoliposome studies of purified FUN26 demonstrate robust nucleoside and nucleobase uptake into the luminal volume for a broad range of substrates. This transport activity is sensitive to nucleoside modifications in the C(2')- and C(5')-positions on the ribose sugar and is not stimulated by a membrane pH differential. [(3)H]Adenine nucleobase transport efficiency is increased ∼4-fold relative to nucleosides tested with no observed [(3)H]adenosine or [(3)H]UTP transport. FUN26 mutational studies identified residues that disrupt (G463A or G216A) or modulate (F249I or L390A) transporter function. These results demonstrate that FUN26 has a unique substrate transport profile relative to known ENT family members and that a purified ENT can be reconstituted in proteoliposomes for functional characterization in a defined system.

Indexed as

Base SequenceDNA PrimersEquilibrative Nucleoside Transport ProteinsKineticsMembrane Transport ProteinsPolymerase Chain ReactionProteolipidsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSolubilityDNA PrimersEquilibrative Nucleoside Transport ProteinsFUN26 protein, S cerevisiaeMembrane Transport ProteinsProteolipidsproteoliposomesSaccharomyces cerevisiae ProteinsMembrane ProteinMembrane TransportMembrane Transporter ReconstitutionNucleoside/Nucleotide TransportTransporter

Identifiers

PMID25035431
PMCPMC4148870
OpenAlexW2086599584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.